Wells Fargo’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15M | Sell |
443,900
-43,118
| -9% | -$1.44M | ﹤0.01% | 1872 |
|
|
2026
Q1 | $14.7M | Sell |
487,018
-160,835
| -25% | -$5.17M | ﹤0.01% | 1735 |
|
|
2025
Q4 | $20.2M | Sell |
647,853
-183,996
| -22% | -$4.53M | ﹤0.01% | 1486 |
|
|
2025
Q3 | $16.8M | Sell |
831,849
-81,844
| -9% | -$1.44M | ﹤0.01% | 1601 |
|
|
2025
Q2 | $15.3M | Sell |
913,693
-202,053
| -18% | -$3.26M | ﹤0.01% | 1597 |
|
|
2025
Q1 | $17.1M | Buy |
1,115,746
+69,707
| +7% | +$1.25M | ﹤0.01% | 1438 |
|
|
2024
Q4 | $23.1M | Buy |
1,046,039
+145,145
| +16% | +$2.64M | 0.01% | 1260 |
|
|
2024
Q3 | $16.2M | Sell |
900,894
-75,066
| -8% | -$1.31M | ﹤0.01% | 1446 |
|
|
2024
Q2 | $15.9M | Buy |
975,960
+50,741
| +5% | +$782K | ﹤0.01% | 1398 |
|
|
2024
Q1 | $13.1M | Buy |
925,219
+633,659
| +217% | +$7.99M | ﹤0.01% | 1534 |
|
|
2023
Q4 | $3.04M | Sell |
291,560
-20,872
| -7% | -$195K | ﹤0.01% | 2574 |
|
|
2023
Q3 | $3.19M | Buy |
312,432
+12,113
| +4% | +$113K | ﹤0.01% | 2440 |
|
|
2023
Q2 | $2.26M | Sell |
300,319
-169,034
| -36% | -$1.37M | ﹤0.01% | 2803 |
|
|
2023
Q1 | $4.15M | Sell |
469,353
-134,623
| -22% | -$1.33M | ﹤0.01% | 2272 |
|
|
2022
Q4 | $5.51M | Buy |
603,976
+245,749
| +69% | +$2.14M | ﹤0.01% | 2015 |
|
|
2022
Q3 | $2.89M | Sell |
358,227
-36,456
| -9% | -$322K | ﹤0.01% | 2425 |
|
|
2022
Q2 | $2.97M | Buy |
394,683
+87,428
| +28% | +$762K | ﹤0.01% | 2483 |
|
|
2022
Q1 | $2.88M | Sell |
307,255
-37,135
| -11% | -$310K | ﹤0.01% | 2947 |
|
|
2021
Q4 | $2.76M | Buy |
344,390
+15,083
| +5% | +$136K | ﹤0.01% | 3177 |
|
|
2021
Q3 | $3.21M | Sell |
329,307
-257,635
| -44% | -$2.41M | ﹤0.01% | 3256 |
|
|
2021
Q2 | $5.81M | Buy |
586,942
+149,407
| +34% | +$1.58M | ﹤0.01% | 2728 |
|
|
2021
Q1 | $5.05M | Buy |
437,535
+54,956
| +14% | +$630K | ﹤0.01% | 2841 |
|
|
2020
Q4 | $3.69M | Sell |
382,579
-95,284
| -20% | -$913K | ﹤0.01% | 3009 |
|
|
2020
Q3 | $4.3M | Sell |
477,863
-66,458
| -12% | -$703K | ﹤0.01% | 2647 |
|
|
2020
Q2 | $6.71M | Sell |
544,321
-579,264
| -52% | -$6.55M | ﹤0.01% | 2185 |
|
|
2020
Q1 | $10.1M | Buy |
1,123,585
+379,576
| +51% | +$3.89M | ﹤0.01% | 1659 |
|
|
2019
Q4 | $7.29M | Sell |
744,009
-54,616
| -7% | -$488K | ﹤0.01% | 2242 |
|
|
2019
Q3 | $5.49M | Buy |
798,625
+174,339
| +28% | +$1.34M | ﹤0.01% | 2464 |
|
|
2019
Q2 | $5.76M | Sell |
624,286
-81,876
| -12% | -$987K | ﹤0.01% | 2446 |
|
|
2019
Q1 | $11.1M | Buy |
706,162
+9,151
| +1% | +$161K | ﹤0.01% | 1847 |
|
|
2018
Q4 | $10.7M | Sell |
697,011
-368,180
| -35% | -$7.55M | ﹤0.01% | 1808 |
|
|
2018
Q3 | $22.9M | Buy |
1,065,191
+330,397
| +45% | +$7.67M | 0.01% | 1418 |
|
|
2018
Q2 | $17.9M | Buy |
734,794
+6,392
| +0.9% | +$130K | 0.01% | 1589 |
|
|
2018
Q1 | $12.4M | Sell |
728,402
-101,159
| -12% | -$1.98M | ﹤0.01% | 1826 |
|
|
2017
Q4 | $15.7M | Sell |
829,561
-771,239
| -48% | -$11.6M | ﹤0.01% | 1648 |
|
|
2017
Q3 | $28.2M | Sell |
1,600,800
-253,189
| -14% | -$5.7M | 0.01% | 1213 |
|
|
2017
Q2 | $61.6M | Sell |
1,853,989
-55,331
| -3% | -$1.71M | 0.02% | 757 |
|
|
2017
Q1 | $61.3M | Buy |
1,909,320
+210,188
| +12% | +$7.17M | 0.02% | 755 |
|
|
2016
Q4 | $61.6M | Sell |
1,699,132
-349,996
| -17% | -$14M | 0.02% | 716 |
|
|
2016
Q3 | $94.3M | Sell |
2,049,128
-421,812
| -17% | -$22M | 0.03% | 529 |
|
|
2016
Q2 | $124M | Buy |
2,470,940
+290,687
| +13% | +$15.5M | 0.05% | 411 |
|
|
2016
Q1 | $117M | Buy |
2,180,253
+217,964
| +11% | +$12.8M | 0.05% | 414 |
|
|
2015
Q4 | $129M | Sell |
1,962,289
-99,606
| -5% | -$6.16M | 0.05% | 390 |
|
|
2015
Q3 | $116M | Sell |
2,061,895
-529,824
| -20% | -$34.4M | 0.05% | 413 |
|
|
2015
Q2 | $153M | Sell |
2,591,719
-342,013
| -12% | -$21.1M | 0.06% | 361 |
|
|
2015
Q1 | $183M | Buy |
2,933,732
+367,227
| +14% | +$21.4M | 0.07% | 313 |
|
|
2014
Q4 | $148M | Buy |
2,566,505
+252,536
| +11% | +$14.1M | 0.06% | 355 |
|
|
2014
Q3 | $124M | Buy |
2,313,969
+71,928
| +3% | +$3.81M | 0.05% | 394 |
|
|
2014
Q2 | $118M | Buy |
2,242,041
+29,206
| +1% | +$1.49M | 0.05% | 426 |
|
|
2014
Q1 | $117M | Buy |
2,212,835
+49,066
| +2% | +$2.27M | 0.05% | 418 |
|
|
2013
Q4 | $86.7M | Sell |
2,163,769
-432,607
| -17% | -$17M | 0.04% | 495 |
|
|
2013
Q3 | $98.1M | Sell |
2,596,376
-1,248,647
| -32% | -$48.7M | 0.05% | 419 |
|
|
2013
Q2 | $151M | Buy |
+3,845,023
| New | +$150M | 0.08% | 302 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Wells Fargo's TEVA Position: Q2 2026 in Review
Wells Fargo reduced its Teva Pharmaceuticals (TEVA) stake by 8.9% in Q2 2026, selling an estimated $1.44M and leaving 443,900 shares worth $15M. The position accounts for ﹤0.01% of the portfolio, ranked #1872.
Wells Fargo first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $183M in Q1 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Wells Fargo held 443,900 shares of Teva Pharmaceuticals worth $15M as of Q2 2026.
- Wells Fargo sold 43,118 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.44M.
- Teva Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1872 holding.
- Wells Fargo first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's Teva Pharmaceuticals position peaked at $183M in Q1 2015.
- 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.